pembrolizumab
merck
['key,note,716', 'melanoma', 'keynote-716']
excellent presentation from &amp; #sitc member on the final dmfs analysis of the keynote-716 study of adjuvant #immunotherapy for #melanoma at #asco23 
Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.